Skybiotech Healt

{
  "main_header": {
    "sid": 364572,
    "name": "Skybiotech Healt",
    "stock_name": "Skybiotech Healt",
    "full_name": "Skybiotech Healthcare Limited",
    "name_url": "stocks-analysis/skybiotech-healt",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "138.90",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "138.90",
    "mcapval": "27.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512036,
    "symbol": "",
    "ind_name": "Garments & Apparels",
    "ind_code": 67,
    "indexname": "India SENSEX",
    "isin": "INE393H01016",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "6 ",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/skybiotech-healt-364572-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Skybiotech Healthcare Limited is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/skybiotech-healthcare-limited-is-rated-strong-sell-3949143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SkybiotechHealt_mojoScore_3949143.png",
        "date": "2026-04-16 10:10:16",
        "description": "Skybiotech Healthcare Limited is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Dec 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Kapil Cotex Ltd Stock Hits 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kapil-cotex-ltd-stock-hits-52-week-low-amid-continued-downtrend-3853335",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KapilCotexLtd_priceRelatedfactors_3853335.png",
        "date": "2026-02-24 15:40:08",
        "description": "Kapil Cotex Ltd, a player in the Garments & Apparels sector, recorded a fresh 52-week low of Rs.116.45 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and operational metrics."
      },
      {
        "title": "Kapil Cotex Ltd Stock Falls to 52-Week Low of Rs.126.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kapil-cotex-ltd-stock-falls-to-52-week-low-of-rs12645-3851155",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KapilCotexLtd_priceRelatedfactors_3851155.png",
        "date": "2026-02-23 09:42:14",
        "description": "Kapil Cotex Ltd, a player in the Garments & Apparels sector, has recorded a fresh 52-week low of Rs.126.45 today, marking a significant decline amid persistent downward momentum. The stock’s recent performance reflects ongoing pressures that have weighed on its valuation and market standing."
      },
      {
        "title": "Skybiotech Healthcare Q3 FY26: Mounting Losses Signal Deepening Operational Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/skybiotech-healthcare-q3-fy26-mounting-losses-signal-deepening-operational-crisis-3842794",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SkybiotechHealt_quaterlyResult_3842794.png",
        "date": "2026-02-16 14:22:02",
        "description": "Skybiotech Healthcare Limited reported a net loss of ₹0.48 crores for Q3 FY26 (Oct-Dec'25), marking a sequential deterioration of 54.84% from Q2 FY26's loss of ₹0.31 crores. The micro-cap garments and apparels company, with a market capitalisation of just ₹27.00 crores, continues to struggle with operational inefficiencies as revenue collapsed 50.00% quarter-on-quarter to ₹0.96 crores. The stock traded at ₹144.90 on February 16, 2026, down 35.54% over the past year, reflecting persistent investor concerns about the company's viability."
      },
      {
        "title": "Are Kapil Cotex Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-kapil-cotex-ltd-latest-results-good-or-bad-3840595",
        "imagepath": "",
        "date": "2026-02-14 19:58:19",
        "description": "Kapil Cotex Ltd's latest financial results for Q2 FY26 reveal significant operational challenges. The company reported a net loss of ₹0.31 crores, which marks a substantial deterioration compared to the previous quarter. Revenue for the quarter stood at ₹1.92 crores, reflecting a quarter-on-quarter decline of 19.67%, although it did show a year-on-year growth of 20.00% compared to the same quarter last year. This inconsistency in revenue generation highlights the company's struggle to maintain stable business momentum.\n\nThe operating margin has shifted dramatically into negative territory at -11.46%, down from a positive margin of 3.35% in the prior quarter, indicating severe operational inefficiencies. The profit after tax (PAT) margin also fell to -16.15%, further emphasizing the company's profitability issues.\n\nThe company has been facing difficulties in its core textile operations, leading to a pivot to..."
      },
      {
        "title": "Kapil Cotex Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kapil-cotex-ltd-is-rated-strong-sell-3834889",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KapilCotexLtd_mojoScore_3834889.png",
        "date": "2026-02-12 10:10:26",
        "description": "Kapil Cotex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 December 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 12 February 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 182,
    "sid": "364572",
    "stock_news_url": "https://www.marketsmojo.com/news/skybiotech-healthcare-limited-364572"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Skybiotech Healthcare Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L17100MH1983PLC031114</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: NISHI JAIN <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: kapilcotexlimited@yahoo.co.in</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: PRAKASHCHANDRA RATHI <br/> Designation: CFO AND DIRECTOR <br/> EmailId: rathiprakashchandra@yahoo.in</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Apr-2026",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018 received from RTA",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Mar-2026",
      "details": "Intimation of Trading window closure to consider and approve Audited Financials for the Quarter and year ended on 31st March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Skybiotech Healthcare Limited is Rated Strong Sell

2026-04-16 10:10:16

Skybiotech Healthcare Limited is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Dec 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Kapil Cotex Ltd Stock Hits 52-Week Low Amid Continued Downtrend

2026-02-24 15:40:08

Kapil Cotex Ltd, a player in the Garments & Apparels sector, recorded a fresh 52-week low of Rs.116.45 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and operational metrics.

Read full news article

Kapil Cotex Ltd Stock Falls to 52-Week Low of Rs.126.45

2026-02-23 09:42:14

Kapil Cotex Ltd, a player in the Garments & Apparels sector, has recorded a fresh 52-week low of Rs.126.45 today, marking a significant decline amid persistent downward momentum. The stock’s recent performance reflects ongoing pressures that have weighed on its valuation and market standing.

Read full news article

Skybiotech Healthcare Q3 FY26: Mounting Losses Signal Deepening Operational Crisis

2026-02-16 14:22:02

Skybiotech Healthcare Limited reported a net loss of ₹0.48 crores for Q3 FY26 (Oct-Dec'25), marking a sequential deterioration of 54.84% from Q2 FY26's loss of ₹0.31 crores. The micro-cap garments and apparels company, with a market capitalisation of just ₹27.00 crores, continues to struggle with operational inefficiencies as revenue collapsed 50.00% quarter-on-quarter to ₹0.96 crores. The stock traded at ₹144.90 on February 16, 2026, down 35.54% over the past year, reflecting persistent investor concerns about the company's viability.

Read full news article

Are Kapil Cotex Ltd latest results good or bad?

2026-02-14 19:58:19

Kapil Cotex Ltd's latest financial results for Q2 FY26 reveal significant operational challenges. The company reported a net loss of ₹0.31 crores, which marks a substantial deterioration compared to the previous quarter. Revenue for the quarter stood at ₹1.92 crores, reflecting a quarter-on-quarter decline of 19.67%, although it did show a year-on-year growth of 20.00% compared to the same quarter last year. This inconsistency in revenue generation highlights the company's struggle to maintain stable business momentum. The operating margin has shifted dramatically into negative territory at -11.46%, down from a positive margin of 3.35% in the prior quarter, indicating severe operational inefficiencies. The profit after tax (PAT) margin also fell to -16.15%, further emphasizing the company's profitability issues. The company has been facing difficulties in its core textile operations, leading to a pivot to...

Read full news article

Kapil Cotex Ltd is Rated Strong Sell

2026-02-12 10:10:26

Kapil Cotex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 December 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 12 February 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News